WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New ATCvet 3rd and 4th levels

QL01ENFibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors
QL01FMONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES
QL01FACD20 (Clusters of Differentiation 20) inhibitors
QL01FBCD22 (Clusters of Differentiation 22) inhibitors
QL01FCCD38 (Clusters of Differentiation 38) inhibitors
QL01FDHER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
QL01FEEGFR (Epidermal Growth Factor Receptor) inhibitors
QL01FFPD-1/PDL-1 (Programmed cell death protein 1
/death ligand 1) inhibitors
QL01FGVEGF
/VEGFR (Vascular Endothelial Growth Factor) inhibitors
QL01FXOther monoclonal antibodies and antibody drug conjugates

Last updated: 2021-12-17